In the United States, rivers and their floodplains are well-documented and monitored. Ecuador's largest river, however, remains largely mysterious. Research led by Michigan State University is helping ...
Jaguar Health's (JAGX) Napo Pharmaceuticals announced that the late-breaker abstract Napo submitted to MASCC on additional significant results in adult breast cancer patients from the OnTarget study ...
"We're very pleased that Napo has been granted a meeting with the FDA to discuss Napo's development plans for crofelemer for MVID - a devastating pediatric disease characterized by severe ...
Napo Pharmaceuticals (Napo), a Jaguar Health (Jaguar) family company, announced that the European Patent Office has issued a new patent to Napo for methods of preventing, ameliorating and/or treating ...
SAN FRANCISCO, CA / ACCESSWIRE / August 7, 2019 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”), a commercial stage pharmaceutical company focused on developing novel, sustainably ...
SAN FRANCISCO, CA / ACCESSWIRE / December 20, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the name of its majority owned subsidiary changed from Napo EU S.p.A. to Napo Therapeutics S ...
As announced, initial proof-of-concept results from the ongoing investigator-initiated trial in Abu Dhabi show crofelemer reduced the required total parenteral nutrition in the first participating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results